Visit COVID-19 resources

[Skip to Content]

Aflibercept as primary treatment for myopic choroidal neovascularisation: a retrospective study – (Eye Journal AOP)

30 October 2015

This news item is available to RCOphth members only, please log in below to access.

Members Login